The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

Kidney International

Volumn 49, Issue 1, 1996, Pages 209-216

  Murgia, Maria G ^a   Jordan, Samantha ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT;

EID: 0030064388     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.28     Document Type: Article

References (43)

1. CALNE RY, THIRU S, MCMASTER P, CRADDOCK GN, WHITE DJG, EVANS DB, DUNN DC, PENTLOW BD: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323-1327, 1978
2. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
3. KAHAN BD: Development of synergistic immunosuppressive drug regimens based upon cyclosporine. Kidney Int 44(Suppl 43):S12-S15, 1993
4. VEZINA C: Antimicrobial activity of streptomyces and fungi isolated from Rapa Nui soil samples. Fifth Annual Meeting, the Canadian Society of Chemotherapy, Toronto, April 16, 1969
5. BAKER H, SIDOROWIEZ A, SEHGAL SN, VEZINA C: Rapamycin, a new fungal antibiotic. J Antibiot (Tokyo) 31:539-545, 1978
6. MARTEL RR, KLICIUS J, GALET S: Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55:48-51, 1977
7. CALNE RY, COLLIER DS, LIM S, POLLARD SG, SAMAAN A: Rapamycin for immunosuppression in organ allografting. (letter) Lancet 2:227, 1989
8. MORRIS RE, MEISER BM: Identification of a new pharmacologic action for an old compound. (letter) Med Sci Res 17: 877, 1989
9. STEPKOWSKI SM, CHEN H, DALOZE P, KAHAN BD: Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 51:22-26, 1991
10. WARNER LM, ADAMS LN, SEHGAL SN: Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arthr Rheum 37:289-297, 1994
11. CARLSON RP, BAEDER WL, CACCESE RG, WARNER LM, SEHGAL SN: Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases. Ann NY Acad Sci 23:86-113, 1993
12. KAHAN BD, GIBBONS S, TEJPAL N, STEPKOWSKI S, CHOU TC: Synergistic interaction of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 51:232-239, 1991
13. CHUNG J, KUO CJ, CRABTREE GR, BLENIS J: Rapamycin-FK506 specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinase. Cell 69:1227-1236, 1992
14. BROWN EJ, ALBERS MW, SHIN TB, ICHIKAWA K, KEITH CT, LANE WS, SCHREIBER SL: A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758, 1994
15. NOURSE J, FIRPO E, FLANAGAN WM, COATS S, POLYAK K, LEE MH, MASSAGUE J, CRABTREE GR, ROBERTS JM: Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573, 1994
16. KUO CJ, CHUNG J, FIORENTINO DF, FLANAGAN WM, BLENIS J, CRABTREE GR: Rapamycin selectively inhibits interleukin-2 activation of p70 s6 kinase. Nature 358:70-73, 1992
17. CALVO V, CREWS CM, VIK TA, BIERER BE: Interleukin 2 stimulation of p70 s6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci USA 89:7571-7575, 1992
18. cdc2 kinase activation in T lymphocytes. J Biol Chem 268:22737-22745, 1993
19. KAHAN BD, CHANG JY, SEHGAL SN: Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 52:185-191, 1991
20. LINDHOLM A, KAHAN BD: Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54:205-218, 1993
21. BROWN SCW, O'REILLY PH: Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard. J Urol 146:675-679, 1991
22. LEWIS R, PODBIELSKI J, SPRAYBERRY S, MUNSELL M, KATZ S, RUBIN M, KIMBALL P, VAN BUREN CT, KERMAN R, KAHAN BD: Stability of renal allograft glomerular filtration rate associated with long-term use of Cyclosporine A. Transplantation 55:1014-1017, 1993
23. VATHSALA A, WEINBERG RB, SCHOENBERG L, GREVEL J, DUNN J, GOLDSTEIN RA, VAN BUREN CT, LEWIS RM, KAHAN BD: Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 21:3670-3673, 1989
24. LINDHOLM A, ALBRECHTSEN D, TUFVESON G, KARLBERG I, PERSSON NN, GROTH CG: A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Transplantation 54:624-631, 1992
25. QUESNIAUX VFJ, WEHRLI S, STEINER C, JOERGENSEN J, SCHUURMA HJ, HERRMANN P, SCHREIR MH, SCHULER W: The inimunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo. Blood 84:1543-1552, 1994
26. KOHICHIZO T, LYMANN SD, SUDO T, CLARK SC, OGAWA M: Enhancement of murine hematopoiesis by synergistic interaction between steel factor (ligand for c-kit), interleukin-11 and other early acting factors in culture. Blood 79:2855-2860, 1992
27. LIESCHKE GJ, BURGESS AW: Granulocyte macrophage colony-stimulating factor. Part 1. N Engl J Med 327:28-35; 99-106, 1992
28. TERAMURA M, KATACHIRA J, HOSHINO S, MOTOGI T, OSIMI K, MISOGUCHI H: Effect of recombinant hemopoietic growth factors on human megakaryocyte colony formation in serum-free culture. Exp Hematol 17:1011-1016, 1989
29. MASUR EM, COHEN JL, WONG GG, CLARK SC: Modest stimulatory effect of recombinant human GM-CSF on colony growth from peripheral blood megakaryocyte colony formation. Exp Hematol 15:1128-1133, 1987
30. GEIFFIN JD, RAMBALDI A, VELLENZA E, YOUNG DC, OSTAPOUCIA D, CANNISTRA S: Secretion of interleukin-1 by acute myeloblastoid leukemia cells in vitro induces endothelial cells secrete colony stimulating factors. Blood 70:1218-1221, 1987
31. GANSER A, LINDENMANN A, SEIPELT G, OTTMANN OG, HERRMANN F, EDER M, FRISCH H, SCHULZ G, MERTELSMANN R, HOELSER D: Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 76:666-676, 1990
32. ISHIBASHI T, KIMURA H, UCHIDA T, KARIYONE S, FREISE P, BURSTEIN SA: Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86:5953, 1989
33. FUSE A, KAKUDA H, SHIRUE Y, DAMME JV, BILLIQU A, SATO T: Interleukin-6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br J Haematol 77:32-36, 1991
34. BRUNO E, HOFFMAN R: Effect of interleukin 6 on in vitro human megakaryocytopoiesis: Its interaction with other cytokines. Exp Hematol 17:1038-1043, 1989
35. QUESINAUX VFJ, CLARK SC, TURUER K, FAGG B: Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood 80:1218, 1992
36. TERAMURA M, KOBAYASHI S, HOSHINO S, OSHIMIK K, MISOGUCHI H: Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 79:327-331, 1992
37. KOBAYASHI S, TERAMURA M, SUGAWARA I, OSHIMI K, MIZOGUCHI H: Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 81:889-893, 1993
38. PAUL SR, BENNETT F, CALVETTI JA, KELLEHER CR, WOOD RM, O'HARA JR, LEARY AC, SIBLEY B, CLARK SC: Molecular cloning of a cDNA encoding interleukin-11, a stromal cell derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87:7512-7516, 1990
39. YONEMURA Y, KAWAKITA M, MASUDA T, FUJIMOTO K, KATO K, TAKATSUKI K: Synergistic effects of interleukin-3 and interleukin-11 on murine megakaryocytopoiesis in serum-free culture. Exp Hematol 20:1011-1016, 1992
40. BURSTEIN SA, MEI R, HEUTHORN J, FREISI P, TURNER K: Leukemia inhibitory factor and interleukin-11 promote the maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153:305-310, 1992
41. NEBEN TY, LOEBELENZ J, HAYES L, MCCARTHY K, STOUDEMIRE J, SCHAUB R, GOLDMAN SJ: Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 81:901-908, 1993
42. DU XX, WILLIAMS DA: Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenviroment. Blood 83: 2023-2030, 1994
43. DI JOSEPH JF, SHARMA RN, CHANG JY: The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 53:507-513, 1992